 ALPHARETTA, Ga., Nov. 16, 2020 GLOBE NEWSWIRE -- Clearside Biomedical, Inc. Nasdaq: CLSD, a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that two presentations of Clearside preclinical and clinical data were given at the virtual American Academy Ophthalmology AAO 2020 Annual Meeting. 